A Randomized, Single-blind Trial of LI-TMS and AVS for Stoke Recovery in Healthy Participants (Phase 1).
Launched by SIBERIAN SCIENTIFIC RESEARCH AND TEST CENTER FOR BIOMEDICAL ENGINEERING · Sep 23, 2024
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Stroke is a leading cause of disability worldwide, significantly impacting individuals; quality of life and their ability to perform daily activities. Rehabilitation is critical for stroke survivors as it aims to restore function, improve mobility, and enhance overall well-being.
Auditory-visual stimulation (AVS) is a stroke rehabilitation technique that combines auditory and visual stimuli to promote cognitive and motor recovery. This approach is based on the principles of neuroplasticity, which suggest that engaging multiple senses through receptor systems can promote brain plasticity an...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must be in good general health, as verified by reviewing their medical history and physical examination. They must not have any serious illnesses that could be a barrier to the research.
- Exclusion Criteria:
- • 1. somatic and neurological diseases in the exacerbation stage;
- • 2. presence of epileptic seizures on the EEG;
- • 3. cognitive disorders;
- • 4. presence of visual and hearing pathologies that prevent the sessions;
- • 5. women during pregnancy.
About Siberian Scientific Research And Test Center For Biomedical Engineering
The Siberian Scientific Research and Test Center for Biomedical Engineering is a leading institution dedicated to advancing healthcare through innovative biomedical research and development. With a focus on cutting-edge technologies and methodologies, the center conducts rigorous clinical trials to evaluate the safety and efficacy of novel medical devices, therapeutic interventions, and diagnostic tools. By fostering collaboration between researchers, healthcare professionals, and industry partners, the center aims to translate scientific discoveries into practical applications that enhance patient care and improve health outcomes. Committed to excellence and integrity, the center adheres to the highest ethical standards and regulatory guidelines in its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Novosibirsk, Novosibirsk Region, Russian Federation
Patients applied
Trial Officials
Viktor Drobyshev, Dr. Med. Sc.
Principal Investigator
Novosibirsk State Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported